Literature DB >> 28830262

Nanocarriers in advanced drug targeting: setting novel paradigm in cancer therapeutics.

Md Habban Akhter1, Md Rizwanullah1, Javed Ahmad2, Mohamed Jawed Ahsan3, Md Ali Mujtaba4, Saima Amin1.   

Abstract

Cancer has been growing nowadays consequently high number of death ascertained worldwide. The medical intervention involves chemotherapy, radiation therapy and surgical removal. This conventional technique lacking targeting potential and harm the normal cells. In drug treatment regimen, the combination therapy is preferred than single drug treatment module due to higher internalization of chemotherapeutics in the cancer cells both by enhance permeation retention effect and by direct cell apoptosis. The cancer therapeutics involves different methodologies of delivering active moiety to the target site. The active and passive transport mode of chemotherapeutic targeting utilizes advance nanocarriers. The nanotechnological strategic treatment applying advance nanocarrier greatly helps in mitigating the cancer prevalence. The nanocarrier-incorporating nanodrug directed for specific area appealed scientist across the globe and issues to be addressed in this regard. Therefore, various techniques and approaches invented to meet the objectives. With the advances in nanomedicine and drug delivery, this review briefly focused on various modes of nanodrug delivery including nanoparticles, liposomes, dendrimer, quantum dots, carbon nanotubes, metallic nanoparticles, nanolipid carrier (NLC), gold nanoshell, nanosize cantilevers and nanowire that looks promising and generates a novel horizon in cancer therapeutics.

Entities:  

Keywords:  Drug targeting; cancer therapeutics; nanocarrier; nanotechnology

Mesh:

Substances:

Year:  2017        PMID: 28830262     DOI: 10.1080/21691401.2017.1366333

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  15 in total

Review 1.  Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.

Authors:  Md Habban Akhter; Irfan Ahmad; Mohammad Y Alshahrani; Alhanouf I Al-Harbi; Habibullah Khalilullah; Obaid Afzal; Abdulmalik S A Altamimi; Shehla Nasar Mir Najib Ullah; Abhijeet Ojha; Shahid Karim
Journal:  Gels       Date:  2022-01-28

2.  Mapping Intellectual Structure and Research Performance for the Nanoparticles in Pancreatic Cancer Field.

Authors:  Xuan Zhu; Qingquan Kong; Xing Niu; Lijie Chen; Chunlin Ge
Journal:  Int J Nanomedicine       Date:  2020-08-05

3.  Heparin coated meta-organic framework co-delivering doxorubicin and quercetin for effective chemotherapy of lung carcinoma.

Authors:  Xiaojun Sun; Yongxing Li; Liang Xu; Xinyu Shi; Mengmin Xu; Xuefang Tao; Guobiao Yang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

Review 4.  The Biological Roles of Exosomal Long Non-Coding RNAs in Cancers.

Authors:  Miao Da; Hao Jiang; Yangyang Xie; Weili Jin; Shuwen Han
Journal:  Onco Targets Ther       Date:  2021-01-12       Impact factor: 4.147

5.  Therapeutic strategies and potential implications of silver nanoparticles in the management of skin cancer.

Authors:  Shaloam Dasari; Clement G Yedjou; Robert T Brodell; Allison R Cruse; Paul B Tchounwou
Journal:  Nanotechnol Rev       Date:  2020-12-31       Impact factor: 7.848

Review 6.  Improvement of Gold Nanorods in Photothermal Therapy: Recent Progress and Perspective.

Authors:  Shengnan Liao; Wang Yue; Shuning Cai; Quan Tang; Weitong Lu; Lingxiao Huang; Tingting Qi; Jinfeng Liao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer.

Authors:  Shuai Ren; Lina Song; Ying Tian; Li Zhu; Kai Guo; Huifeng Zhang; Zhongqiu Wang
Journal:  Int J Nanomedicine       Date:  2021-11-06

Review 8.  The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?

Authors:  Manikandan Muthu; Sechul Chun; Judy Gopal; Gyun-Seok Park; Arti Nile; Jisoo Shin; Juhyun Shin; Tae-Hyoung Kim; Jae-Wook Oh
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

9.  Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells.

Authors:  Chenggong Liu; Qiongmei Han; Hua Liu; Cuirong Zhu; Wei Gui; Xiaodong Yang; Wansen Li
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 10.  Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges.

Authors:  Md Rizwanullah; Mohammad Zaki Ahmad; Mohammed M Ghoneim; Sultan Alshehri; Syed Sarim Imam; Shadab Md; Nabil A Alhakamy; Keerti Jain; Javed Ahmad
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.